Commentary

Later HD, Less HD, No HD: A New Paradigm?

Later HD, Less HD, No HD: A New Paradigm?

By

Recent studies have cast doubt on the universal superiority of the conventional approach to dialysis.

Clinical Trials in Surgery: A New Paradigm

Clinical Trials in Surgery: A New Paradigm

By

Randomized clinical trials are often considered the highest level on which medical care should be based.

The Looming Battle for ESRD Fountains

The Looming Battle for ESRD Fountains

As the rate of acceleration in ESRD incidence decline, physicians should expect heightened battles for the ESRD fountains.

The Psychological Impact of Prostate Cancer

The Psychological Impact of Prostate Cancer

By

Patients diagnosed with prostate cancer often struggle with their diagnosis.

Artificial Kidney Technology Moves Forward

Artificial Kidney Technology Moves Forward

By

If ESRD patients face increasing difficulty getting a kidney transplant in coming years, they may see an artificial kidney as the next best alternative.

Recent Developments in Prostate Cancer Management

Recent Developments in Prostate Cancer Management

By

Additional novel medical therapies to treat prostate cancer and earlier use of the existing medical therapies are the future of prostate cancer management.

Important Prostate Cancer Advances of the Last 10 Years

Important Prostate Cancer Advances of the Last 10 Years

By

Advances in prostate cancer screening, management and therapeutics have vastly improved patient care.

Therapeutic Non-adherence: An Ongoing Problem

Therapeutic Non-adherence: An Ongoing Problem

By

No matter how much pharmacologic therapy advances, patient behavior will remain a significant factor in the outcomes achieved.

Should We Always Treat Edema?

Should We Always Treat Edema?

By

We may feel good treating a patient's edema, but is fluid retention always harmful?

Prostate Cancer Genetics: Ready for Clinical Use?

Prostate Cancer Genetics: Ready for Clinical Use?

By

For decades, prostate cancer risk (PCa) stratification was based primarily on the architectural pattern of the tumor.

The Renal & Urology News Top 5 Lists for 2014

The Renal & Urology News Top 5 Lists for 2014

By

Among the most important challenges in producing a medical newspaper is deciding what studies or topics on which to report.

Physicians and the Medical-Industrial Complex

Physicians and the Medical-Industrial Complex

By

Eisenhower warned Americans to beware of the "military-industrial complex" as it can overwhelm us.

The Ebola Threat: Why Not an Outbreak Here?

The Ebola Threat: Why Not an Outbreak Here?

By

The separation of continents no longer provides a secure buffer against the spread of communicable diseases from far-flung places.

Big Data, Transparency and Accountability

Big Data, Transparency and Accountability

By

We crave clinical and scientific data, yet we grieve the performance-based data increasingly directed toward us.

Nephrologists Woefully Underpaid in U.S vs. Canada

Nephrologists Woefully Underpaid in U.S vs. Canada

By

This higher level of dialysis care in Canada is partly owed to substantially higher reimbursement fees for nephrologists.

Why Not A Federal Medical License?

Why Not A Federal Medical License?

By

When we move from one state to another, typically we must obtain a driver's license from the state to which we are relocating.

Medical Research and the Federal Shutdown

Medical Research and the Federal Shutdown

By

After the end of 16-day federal shutdown in October, media headlines touted the financial impact on America and the cost of restarting the government.

Genetic Risk and PCa Treatment: A New Era Dawning

Genetic Risk and PCa Treatment: A New Era Dawning

By

For men at risk of developing prostate cancer (PCa), prophylactic prostatectomy seems almost irrational for several reasons

Self-Cannibalizing for Peritoneal Dialysis Growth?

Self-Cannibalizing for Peritoneal Dialysis Growth?

By

In the nephrology community, there have been heightened discussions and apparent enthusiasm about the revival of PD as the prototype for home dialysis.

Hemoglobin Levels Fall, Transfusions On the Rise

Hemoglobin Levels Fall, Transfusions On the Rise

By

Two studies presented at the recent NKF Spring Clinical Meetings provide more evidence of a trend toward decreasing use of ESAs and decreasing hemoglobin levels.

Reflections on the EAU Annual Congress

Reflections on the EAU Annual Congress

By

Having just returned from the always-stimulating European Association of Urology annual congress, I'd like to share a few impressions.

Why Not 24/7 Dialysis Urgent Care?

Why Not 24/7 Dialysis Urgent Care?

By

Almost half a million Americans depend on chronic dialysis therapy to survive.

Physicians: Managers of Risk

Physicians: Managers of Risk

By

Physicians are more often defined by their ability to diagnose, treat, and research a disease than their willingness to manage its spectrum of risk.

The Rise of the Coffee Shop Doctor

The Rise of the Coffee Shop Doctor

By

How often have you met for business in a Starbucks, Coffee Bean, or any other coffee shop?

Highlights of Kidney Week 2012

Highlights of Kidney Week 2012

By

Kidney Week 2012, held in San Diego, is now history and as usual I like to reflect on the world's biggest and most prestigious meeting for kidney specialists.

Obesity and Prostate Cancer Risk

Obesity and Prostate Cancer Risk

By

Although data suggest that cancer rates are also higher in obese patients, the associations are largely based on observational/population studies.

Obama, Romney Debate Health Care in NEJM

Obama, Romney Debate Health Care in NEJM

By

President Obama and Mitt Romney square off on American health reform in the New England Journal of Medicine.

How About Twice-Weekly Hemodialysis?

How About Twice-Weekly Hemodialysis?

By

In recent trips to India, China, Brazil, and other countries, I was intrigued by large numbers of patients with end-stage renal disease who underwent hemodialysis (HD) less frequently than three times a week.

Outlook Brightens for CRPC Patients

Outlook Brightens for CRPC Patients

By

In the past few years, urologists have seen some significant developments related to the treatment of metastatic castration-resistant prostate cancer (CRPC).

Sign Up for Free e-newsletters